| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |